Viral hepatitis and the immunological response: a review
DOI:
https://doi.org/10.18227/hd.v1i1.7464Palavras-chave:
Hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, immune systemResumo
Introduction: In Brazil, viral hepatitis is infectious disease of compulsory notification and is considered a serious public health problem. Infections with A, B, C, D or E viruses trigger the activation of immune system molecules and cells at the level of innate and acquired immunity. Objective: The present study aimed to review the knowledge about viral hepatitis and the immune system's performance against these infections. Methods: This is a literature overview from academic books and scientific articles available in the Scientific Electronic Library Online, US National Library of Medicine National Institutes of Health and Google Scholar databases. Having as key words hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E and immune system. The relevant articles corresponding to the period between 1974 and 2017 were selected. Development: Viral hepatitis is characterized by inflammation in liver cells caused by groups of viruses that have hepatotropism in common. The diagnosis is made through serological methods and molecular biology techniques. The approach of the immune system in relation to the combat of this infection follows same particularities. Conclusion: This review demonstrated that the determination of the etiologic agent is essential for the conduct to be taken with the infected individual. Moreover, the immune system is directed related to the viruses elimination, presenting some particularities. In addition, this review highlights that the vaccination is the main responsible for reducing people infected by viruses A and B.
Downloads
Referências
Abbas, A. K., A. H. Lichtman and S. Pillai (2015). Imunologia Celular e Molecular. Rio de Janeiro, Elsevier.
Abbas, R. J. (2012). Demokrasi di aras lokal : praktek politik elite lokal di Maluku Utara. Banguntapan, Bantul, Yogyakarta, Cerah Media.
Abe, A., K. Inoue, T. Tanaka, J. Kato, N. Kajiyama, R. Kawaguchi, S. Tanaka, M. Yoshiba and M. Kohara (1999). "Quantitation of hepatitis B virus genomic DNA by realtime detection PCR." J Clin Microbiol 37(9): 2899-2903.
Akira, A. K., k. Takedo and T. Kaisho (2001). "Toll-like receptors: critical proteins linking innate and acquired immunity." Nature Immunology 2: 675-680.
Akira, S., S. Uematsu and O. Takeuchi (2006). "Pathogen recognition and innate immunity." Cell 124: 783-801.
Babinski, C. E., E. M. A. Nunes, R. Locatelli and S. E. Mella Jr (2008). "Prevalência de infecção pelo vírus da hepatite a, hepatite b e hepatite c, no município de Maringá, norte do Paraná, no período de 2001 a 2004." Revista Saúde e Pesquisa 1: 117-124.
Biermer, M., R. Puro and R. J. Schneider (2003). "Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB." J Virol 77(7): 4033-4042.
Birnie, G. G., E. M. Quigley, G. B. Clements, E. A. Follet and G. Watkinson (1983). "Endoscopic transmission of hepatitis B virus." Gut 24(2): 171-174.
Brandão, A. B. M., S. C. Fuchs, M. A. A. Silva and L. F. Emer (2001). "Diagnóstico da hepatite C na prática médica: revisão da literatura." Rev Panamericana de Salud Publica 9: 161-168.
Castet, V., C. Fournier, A. Soulier, R. Brillet, J. Coste, D. Larrey, D. Dhumeaux, P. Maurel and J. M. Pawlotsky (2002). "Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro." J Virol 76(16): 8189-8199.
Charlton, M., E. Gane, M. P. Manns, R. S. Brown Jr, M. P. Curry, P. Y. Kwo, R. J. Fontana, R. Gilroy, L. Teperman, A. J. Muir, J. G. McHutchison, W. T. Symonds, B. D;, B. Kirby, H. Dvory-Sobol, J. Denning, S. Arterburn, D. Samuel, X. Forns and T. N.A. (2015). "Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. ." Gastroenterology 148(108-117).
Clemens, S. A. C., J. C. Fonseca, T. Azevedo, A. Cavalcanti, T. R. Silveira, M. C. Castilho and R. Clemens (2000). "Soroprevalência para hepatite A e hepatite B em quatro centros no Brasil." Revista da Sociedade Brasileira de Medicina Tropical 33: 1-10.
Coelho-Castelo, A. A. M., A. P. F. Trombone and C. D. Rocha, Lorenzi, J.C.C., (2009). "Resposta imune a doenças infecciosas." Revista Medicina de Ribeirão Preto 42: 127-142.
Cruvinel, W. M., D. Mesquita Jr, J. A. P. Araújo, T. T. T. Catelan, A. W. S. S. Souza, N. P. Silva and L. E. C. Andrade (2010). "Sistema imunitário-Parte I, fundamentos da imunidade inata com ênfase nos mecanismos moleculares e celulares da resposta inflamatória." Revista Brasileira de Reumatologia 50: 434-461.
Delves, P. J., S. J. Martin, D. R. Burton and I. M. Roitt (2013). Fundamentos de Imunologia. Rio de Janeiro, Guanabara Koogan.
Delves, P. J. and I. M. Roitt (2000). "The immune system – first of two parts. ." The New England Journal of Medicine343: 37-49.
Dickson, R. C., J. E. Everhart, J. R. Lake, Y. Wei, E. C. Seaberg, R. H. Wiesner, R. K. Zetterman, T. L. Pruett, M. B. Ishitani and J. H. Hoofnagle (1997). "Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database." Gastroenterology 113(5): 1668-1674.
Ebinuma, H., N. Nakamoto, Y. Li, D. A. Price, E. Gostick, B. L. Levine, J. Tobias, W. W. Kwok and K. M. Chang (2008). "Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection." J Virol 82(10): 5043-5053.
Fantini, M. C., C. Becker, G. Monteleone, F. Pallone, P. R. Galle and M. F. Neurath (2004). "Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7." J Immunol 172(9): 5149-5153.
Fares, A. (2015). "Seasonality of hepatitis: a review update." Journal of Family Medicine and Primary Care 4: 96-100.
Ferreira, C. T. and T. R. Silveira (2004). "Hepatites virais: aspectos da epidemiologia e da prevenção." Revista Brasileira de Epidemiologia 7: 473-487.
Ferreira, C. T. and T. R. Silveira (2006). "Viral hepatites prevention by immunization." Jornal de Pediatria 82: S55-S66.
Ferreira, M. S. (2000). "Diagnóstico e tratamento da hepatite B." Revista da Sociedade Brasileira de Medicina Tropical 33: 398-400.
Fonseca, J. C. F. (2002). "Hepatite D." Revista da Sociedade Brasileira de Medicina Tropical 35: 181-190.
Fonseca, J. C. F. (2010). "Histórico das hepatites virais." Revista da Sociedade Brasileira de Medicina Tropical 43: 322-330.
Francisco, P. M. S. B., M. R. DonalisioI, F. J. O. Gabriel and M. B. A. Barros (2015). "Vacinação contra hepatite B em adolescentes residentes em Campinas, São Paulo, Brasil." Revista Brasileira de Epidemiologia 18: 552-567.
Ghany, M. G., D. B. Strader, D. L. Thomas and L. B. Seeff (2009). "Diagnosis, management, and treatment of hepatitis C: an update." Hepatology 49: 1335-1374.
Haffar, S., F. Bazerbachi and J. R. Lake (2015). "Making the case for the development of a vaccination against hepatitis E virus." Liver Int 35(2): 311-316.
Hanafiah, K. M., J. Goeger, A. D. Flaxman and S. T. Wiersma (2013). "Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence." Hepatology 57: 1333-1342.
Heath, W. R. and F. R. Carbone (2001). "Cross-presentation in viral immunity and self-tolerance." Nat Rev Immunol 1(2): 126-134.
Hoofnagle, J. H. (1994). "Therapy of acute and chronic viral hepatitis." Adv Intern Med 39: 241-275.
Hoofnagle, J. H., K. E. Nelson and R. H. Purcell (2012). "Hepatitis E." The New England Journal of Medicine 367: 1237-1244.
Houghton, M. and S. Abrignani (2005). "Prospects for a vaccine against the hepatitis C vírus." Nature 436: 961- 966.
Howard, C. R. (1986). "The biology of hepadnaviruses." J Gen Virol 67 ( Pt 7): 1215-1235.
Ichikawa, S., D. Mucida, A. J. Tyznik, M. Kronenberg and H. Cheroutre (2011). "Hepatic stellate cells function as regulatory bystanders." J Immunol 186(10): 5549-5555.
Itharatana, K. (1988). "[Viral hepatitis B infection. Transmission and prevention for dentists]." J Dent Assoc Thai 38(4): 180-187.
Jaeckel, E., M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, M. Zankel, G. Pastore, M. Dietrich, C. Trautwein and M. P. Manns (2001).
"Treatment of acute hepatitis C with interferon alfa-2b." The New England Journal of Medicine 345: 1452-1457.
Jung, M. K. and E. C. Shin (2016). "Regulatory T Cells in Hepatitis B and C Virus Infections." Immune Netw 16(6): 330-336.
Kumar, V., A. K. Abass and J. C. Aster (2013). Robbins, Patologia Básica. Rio de Janeiro, Elsevier.
Levin, M. L., W. C. Maddrey, J. R. Wands and A. L. Mendeloff (1974). "Hepatitis B transmission by dentists." JAMA 228(9): 1139-1140.
Lok, A. S. F. and B. J. McMahon (2007). "Chronic hepatites B." Hepatology 45: 507-539.
Ly, K. N., J. Xing, R. M. Klevens, R. B. Jiles, J. W. Ward and S. D. Holmberg (2012). "The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. ." Annals of Internal Medicine 156: 271- 278.
Macedo, T. F. S., N. S. Silva, V. Y. N. Silva and T. G. B. Kashiwabara (2013). "Hepatites virais-uma revisão de literatura." Brazilian Journal of Surgery and Clinical Research 5: 55-58.
Machado, P. R. L., M. I. A. S. Araújo, L. Carvalho and E. M. Carvalho (2004). "Mecanismos de resposta imune às infecções." Anais Brasileiros de Dermatologia 79: 647- 664.
Medzhitov, R. and C. A. Janeway, Jr. (2002). "Decoding the patterns of self and nonself by the innate immune system." Science 296(5566): 298-300.
Mesquita Jr, D., J. A. P. Araújo, T. T. T. Catelan, A. W. S. Souza, W. M. Cruvinel, L. E. C. Andrade and N. P. Silva (2010). "Sistema Imunitário-Parte II, fundamentos da resposta imunológica mediada por linfócitos T e B. ." Revista Brasileira de Reumatologia 50: 552-580.
Messina, J. P., I. Humphreys, A. Flaxman, A. Brown, G. S. Cooke, O. G. Pybus and E. Barnes (2015). "Global distribution and prevalence of hepatitis C virus genotypes." Hepatology 61(1): 77-87.
Nagy, P. D. and J. Pogany (2012). "The dependence of viral RNA replication on co-opted host factors." Nature Reviews Microbiology 10(2): 137-149.
Neves, P. D. (2006). Parasitologia Dinâmica. São Paulo, Atheneu.
Ogholikhan, S. and K. B. Schwarz (2016). "Hepatitis Vaccines." Vaccines (Basel) 4(1): 6.
Op De Beeck, A. and J. Dubuisson (2003). "Topology of hepatitis C virus envelope glycoproteins." Rev Med Virol 13(4): 233-241.
Paraná, R. and M. I. Schinoni (2002). "Hepatite E." Revista da Sociedade Brasileira de Medicina Tropical 35: 247- 253.
Peakman, M. and D. Vergani (2011). Imunologia Básica e Clínica. Rio de Janeiro, Elsevier.
Pereira, F. E. L. and C. S. Gonçalves (2003). "Hepatite A." A Revista da Sociedade Brasileira de Medicina Tropical 36: 387-400.
Perrillo, R. (2009). "Benefits and risks of interferon therapy for hepatitis B." Hepatology 49(5 Suppl): S103-111.
Poisson, F., P. Roingeard, A. Baillou, F. Dubois, F. Bonelli, R. A. Calogero and A. Goudeau (1993). "Characterization of RNA-binding domains of hepatitis delta antigen." J Gen Virol 74 ( Pt 11): 2473-2478.
Ransohoff, R. M. and M. A. Brown (2012). "Innate immunity in the central nervous system. ." The Journal of Clinical Investigation 36: 387-400.
Sakaguchi, E., K. Kayano, M. Segawa, M. Aoyagi, I. Sakaida and K. Okita (2001). "[Th1/Th2 imbalance in HCV-related liver cirrhosis]." Nihon Rinsho 59(7): 1259-1263.
Shepard, C. W., L. Finelli and M. J. Alter (2005). "Global epidemiology of hepatitis C virus infection." Lancet Infect Dis 5(9): 558-567.
Shevach, E. M., R. A. DiPaolo, J. Andersson, D. M. Zhao, G. L. Stephens and A. M. Thornton (2006). "The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells." Immunol Rev 212: 60-73.
Silva, A. L., R. R. Vitorino, V. Esperidião-Antonio, E. T. Santos, L. A. Santana, B. D. Henriques and A. P. Gomes(2012). "Hepatites virais: B, C e D: atualização." Revista Brasileira Cliníca Médica 10: 206-218.
Silva, P. C., C. L. Vitral, C. Barcellos, H. Kawa, R. Gracie and M. L. G. Rosa (2007). "Hepatite A no município do Rio de Janeiro, Brasil: padrão epidemiológico e associação das variáveis sócio-ambientais. Vinculando dados do SINAN aos do censo demográfic." Caderno de Saúde Pública 23: 1553-1564.
Stanaway, J. D., A. D. Flaxman, M. Naghavi, C. Fitzmaurice, T. Vos, I. Abubakar, L. J. Abu-Raddad, R. Assadi, N. Bhala, B. Cowie, M. H. Forouzanfour, J. Groeger, K. Mohd Hanafiah, K. H. Jacobsen, S. L. James, J. MacLachlan, R. Malekzadeh, N. K. Martin, A. A. Mokdad, A. H. Mokdad, C. J. Murray, D. Plass, S. Rana, D. B. Rein, J. H. Richardus, J. Sanabria, M. Saylan, S. Shahraz, S. So, V. V. Vlassov, E. Weiderpass, S. T. Wiersma, M. Younis, C. Yu, M. El Sayed Zaki and G. S. Cooke (2016). "The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013." Lancet 388(10049): 1081-1088.
Stephens, P. R. S., M. B. S. C. Oliveira, F. C. Ribeiro and L. A. D. Carneiro (2010). Conceitos e Métodos para a formação de profissionais em laboratório de saúde. Rio de janeiro, EPSJV.
Stevens, A. and J. Lowe (2002). Patologia. São Paulo, Manole.
Strauss, E. (2001). "Hepatite C." Revista da Sociedade Brasileira de Medicina Tropical 34: 69-82.
Tanaka, Y. (2016). "[Latest Treatment of Viral Hepatitis-Overcoming Hepatitis C and Reactivation of Hepatitis B]." Rinsho Byori 64(2): 211-218.
Tohme, R. A. and S. D. Holmberg (2010). "Is sexual contact a major mode of hepatitis C virus transmission?" Hepatology 52: 1497-1505.
Valaydon, Z., M. Pellegrini, A. Thompson, P. Desmond, P. Revill and G. Ebert (2016). "The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde." Clin Transl Immunology 5(12): e115.
van Zonneveld, M., A. B. van Nunen, H. G. Niesters, R. A. de Man, S. W. Schalm and H. L. Janssen (2003).
"Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection." J Viral Hepat 10(4): 294-297.
Vranjac, A. (2006). "Vacina contra hepatite B." Revista Saúde Pública 40: 1137-1140.
Wang, M., D. Xi and Q. Ning (2017). "Virus-induced hepatocellular carcinoma with special emphasis on HBV." Hepatol Int. 11(2):171-180.
Xia, Y., D. Stadler, J. Lucifora, F. Reisinger, D. Webb, M. Hosel, T. Michler, K. Wisskirchen, X. Cheng, K. Zhang, W. M. Chou, J. M. Wettengel, A. Malo, F. Bohne, D. Hoffmann, F. Eyer, R. Thimme, C. S. Falk, W. E. Thasler, M. Heikenwalder and U. Protzer (2016). "Interferongamma and Tumor Necrosis Factor-alpha Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis." Gastroenterology 150(1): 194-205.
Xu, D., J. Fu, L. Jin, H. Zhang, C. Zhou, Z. Zou, J. M. Zhao, B. Zhang, M. Shi, X. Ding, Z. Tang, Y. X. Fu and F. S. Wang (2006). "Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B." J Immunol 177(1): 739-747.
Zein, N. N. (1998). "Interferons in the management of viral hepatitis." Cytokines Cell Mol Ther 4(4): 229-241.
Zhu, J., H. Yamane and W. E. Paul (2010). "Differentiation of effector CD4 T cell populations (*)." Annu Rev. Immunol. 28: 445-489.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Este obra está licenciado com uma Licença Creative Commons Atribuição 4.0 Internacional.
